supp.fit

Resveratrol: study protocols

139 study groups say how much Resveratrol participants took a day. These are the doses the studies gave. They are not a recommendation.

Resveratrol: what the research found →

Dose per serving from products

1,584 products in our catalogue print how much Resveratrol a serving holds.

Most common: 100 mg to 250 mg, 23% of 1,584 products.

Dose per servingProducts
2.5 mg or less
73
2.5 mg to 5 mg
69
5 mg to 10 mg
152
10 mg to 25 mg
155
25 mg to 50 mg
269
50 mg to 100 mg
280
100 mg to 250 mg
366
250 mg to 500 mg
143
over 500 mg
77

Dose per serving from research

136 study groups in 110 studies say how much Resveratrol participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 29% of 136 study groups.

Daily doseStudy groups
10 mg or less
6
10 mg to 25 mg
4
25 mg to 50 mg
10
50 mg to 100 mg
16
100 mg to 250 mg
32
250 mg to 500 mg
40
500 mg to 1 g
23
over 1 g
5

Commonly used together

33 of 139 study groups took Resveratrol with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Epigallocatechin Gallate
7
Vitamin D
5
Soy Isoflavones
3

139 study groups

Study
Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study
2025 · intervention group · Adults aged 63–73 with knee osteoarthritis
500 mg12 weeks67
Resveratrol treatment increases sirtuin 1 levels and alleviates frailty phenotype in knee osteoarthritis patients: a randomised placebo-controlled clinical trial
2025 · resveratrol group · Patients aged 63–75 years with knee osteoarthritis
500 mg16 weeks59
Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study
2018 · resveratrol group · Men and women aged 45–75 with clinically diagnosed knee osteoarthritis, radiographic grade 1–3, and baseline WOMAC pain assessment above 50/96
500 mg90 days55
Correlation between serum pro inflammatory cytokines and clinical scores of knee osteoarthritic patients using resveratrol as a supplementary therapy with meloxicam
2021 · Mlx + Res · Adults aged 45 years or older with mild-to-moderate painful knee osteoarthritis
500 mg90 days50
Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis
2022 · high-dose group (HRV) · Adults over 18 with periodontitis; mean age about 25 years; men and women
500 mg8 weeks40
Sirtuin 1 and Vascular Function in Healthy Women and Men: A Randomized Clinical Trial Comparing the Effects of Energy Restriction and Resveratrol
2023 · resveratrol group · Healthy men aged 55–65 and healthy postmenopausal women, without chronic non-communicable disease or previous cardiovascular disease
500 mg30 days24
Resveratrol and exercise combined to treat functional limitations in late life: A pilot randomized controlled trial
2021 · EX + 500 mg/day resveratrol (EX500) · Adults aged 65 years or older with functional limitations and low physical activity
500 mg12 weeks20
Impact of systemic resveratrol on non-surgical periodontal treatment of smokers: A 12-month randomized clinical trial
2025 · RSV · smoking patients with periodontitis
500 mg180 days19
Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study
2016 · resveratrol group · Patients with active mild to moderate ulcerative colitis
500 mg6 weeks—
Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
2021 · resveratrol · Patients with ADHD; age and sex not specified
500 mg8 weeks—
Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study
2018 · RSV-treated group · Adults with rheumatoid arthritis; 68 women and 32 men enrolled across the study, with 50 assigned to this arm
1 g90 days50
Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis
2022 · middle-dose group (MRV) · Adults over 18 with periodontitis; mean age about 26 years; men and women
250 mg8 weeks40
Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS
2021 · resveratrol group · Women aged 18–40 years with PCOS diagnosed by the Rotterdam criteria
1 g90 days39
Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus
2016 · 300 mg resveratrol · Adults aged 49–78 years with type 2 diabetes mellitus, dementia-free and non-insulin dependent
300 mg1 day36
Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus
2016 · 300 mg resveratrol · Adults aged 40–80 years with type 2 diabetes mellitus
300 mg1 day36
Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
2018 · resveratrol group · Males and females aged 20 to 60 years with nonalcoholic fatty liver disease (NAFLD) and BMI 25 to 35 kg/m²
600 mg12 weeks30
Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial
2024 · resveratrol supplementation · Adults aged 68±7 years, 84% men, with stage 3 CKD and diabetes
400 mg6 weeks28
Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction
2018 · trans-resveratrol · Men and women aged 45–65 with treated hypertension and baseline endothelial dysfunction
300 mg1 day24
Recovery Of Bone And Muscle Mass In Patients With Chronic Kidney Disease And Iron Overload On Hemodialysis And Taking Combined Supplementation With Curcumin And Resveratrol
2019 · Group A (Resveratrol + Curcumin) · Adults with chronic kidney disease and iron overload undergoing hemodialysis; age and sex not restricted
500 mg12 weeks20
Resveratrol and exercise combined to treat functional limitations in late life: A pilot randomized controlled trial
2021 · EX + 1,000 mg/day resveratrol (EX1000) · Adults aged 65 years or older with functional limitations and low physical activity
1 g12 weeks20
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol (Polygonum cuspidatum), Luteolin, and Fisetin (Rhus succedanea)
2021 · higher-dose resveratrol · Male veterans aged 46–57 with Gulf War Illness
600 mg30 days9
Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial
2017 · resveratrol · Patients diagnosed with acute Takayasu arteritis
250 mg90 days—
Effects of 90 Days of Resveratrol Supplementation on Cognitive Function in Elders: A Pilot Study
2018 · 300 mg/day resveratrol · Sedentary, overweight adults aged 65–93 years
300 mg90 days—
Effects of 90 Days of Resveratrol Supplementation on Cognitive Function in Elders: A Pilot Study
2018 · 1000 mg/day resveratrol · Sedentary, overweight adults aged 65–93 years
1 g90 days—
Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial
2018 · Resv500 arm · Adults aged 40 years or older with diagnosed type 2 diabetes; median age 66 years, predominantly men, all women postmenopausal
500 mg26 weeks65
Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: A 24-month randomised, double-blind, placebo-controlled, crossover study
2021 · resveratrol · Postmenopausal women aged 45–85 years
150 mg1 year125
δ-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial
2023 · TRM · Adults aged 18–60 years with metabolic syndrome
300 mg24 weeks41
Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis
2022 · low-dose group (LRV) · Adults over 18 with periodontitis; mean age about 27 years; men and women
125 mg8 weeks40
Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus
2016 · 75 mg resveratrol · Adults aged 49–78 years with type 2 diabetes mellitus, dementia-free and non-insulin dependent
75 mg1 day36
Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus
2016 · 150 mg resveratrol · Adults aged 49–78 years with type 2 diabetes mellitus, dementia-free and non-insulin dependent
150 mg1 day36
Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus
2016 · 75 mg resveratrol · Adults aged 40–80 years with type 2 diabetes mellitus
75 mg1 day36
Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus
2016 · 150 mg resveratrol · Adults aged 40–80 years with type 2 diabetes mellitus
150 mg1 day36
Resveratrol has a positive effect on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease
2017 · research group · Patients with stable coronary heart disease and class II stable angina pectoris; age and sex not reported
100 mg60 days30
Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
2020 · resveratrol plus risperidone · Adults aged 18–60 with chronic stable schizophrenia, disease duration of at least 2 years, and a PANSS negative subscale score of at least 15
200 mg8 weeks30
Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults
2013 · trans-resveratrol · Obese but otherwise healthy adults; age range and sex not reported
75 mg6 weeks28
Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults
2014 · resveratrol · Healthy overweight older adults aged 50–75 years
200 mg26 weeks23
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans
2011 · resVida™ (resveratrol) condition · Obese, otherwise healthy men; age range not reported; no family history of diabetes or other endocrine disorder
150 mg30 days11
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol (Polygonum cuspidatum), Luteolin, and Fisetin (Rhus succedanea)
2021 · lower-dose resveratrol · Male veterans aged 46–57 with Gulf War Illness
200 mg30 days9
Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease
2012 · RES group · Caucasian patients after myocardial infarction with coronary artery disease; age and sex not specified
10 mg90 days—
Effects of Resveratrol on Cognitive Performance, Mood and Cerebrovascular Function in Post-Menopausal Women; A 14-Week Randomised Placebo-Controlled Intervention Trial
2017 · resveratrol group · Post-menopausal women aged 45–85 years without the specified excluded conditions
150 mg14 weeks—
Resveratrol supplementation reduces pain experience by postmenopausal women
2017 · trans-resveratrol · Healthy postmenopausal women
150 mg14 weeks—
Long-term resveratrol supplementation improves pain perception, menopausal symptoms, and overall well-being in postmenopausal women: findings from a 24-month randomized, controlled, crossover trial
2020 · resveratrol supplementation · healthy postmenopausal women
150 mg1 year—
The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial
2024 · Study Group · Women aged 35 years or older with infertility, normal ovarian reserve markers, and undergoing IVF
150 mg90 days40
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial
2024 · NR + resveratrol · Adults with peripheral artery disease; mean age 70.73 years in this arm; men and women
125 mg26 weeks33
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
2017 · Group B · Adults with chronic hepatitis C receiving pegylated interferon-α-2b and ribavirin
59.4 mg1 year30
Reversal of Insulin Resistance in Overweight and Obese Subjects by trans-Resveratrol and Hesperetin Combination-Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation
2021 · tRES-HESP · Overweight and obese adults with impaired metabolic health; 9 participants met criteria for prediabetes
90 mg8 weeks29
Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects
2014 · E+R · Healthy overweight women and men, mean age 35 years
200 mg3 days18
Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects
2014 · E+R+S · Healthy overweight women and men, mean age 35 years
200 mg3 days18
Efficacy of a Mouthwash Containing Resveratrol in Reducing Halitosis-related P. gingivalis: A Randomized Triple-blind Trial
2025 · RSV group · Male and female undergraduate dental students aged 20–23 with halitosis due to gingivitis
30 mL7 days17
The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans
2018 · EGCG+RES · Overweight and obese men and premenopausal women; ages not specified
80 mg12 weeks11
Influence of exercise training with resveratrol supplementation on skeletal muscle mitochondrial capacity
2016 · resveratrol plus piperine · healthy young adults
500 mg4 weeks—
Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: A randomized, placebo-controlled study
2017 · equol and resveratrol group · Healthy recently menopausal women aged 50–55 years with hot flashes, anxiety and depressive symptoms
25 mg12 weeks—
Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial
2018 · Resv40 arm · Adults aged 40 years or older with diagnosed type 2 diabetes; median age 66 years, predominantly men, all women postmenopausal
40 mg26 weeks65
Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial
2020 · Resveratrol · Women aged 45–85 years who were postmenopausal for more than 12 months and not taking hormone replacement therapy; community-dwelling, with a range of bone-health status including normal bone density, osteopenia, and osteoporosis.
150 mg1 year63
Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial
2023 · Combo group (CG) · Adults aged 18–45 with acute sciatica due to lumbar disc herniation and low-back pain NRS 5–7
50 mg30 days44
Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial
2023 · Supplement group (SG) · Adults aged 18–45 with acute sciatica due to lumbar disc herniation and low-back pain NRS 5–7
50 mg30 days41
Effects of 12 Weeks of Essential Amino Acids (EAA)-Based Multi-Ingredient Nutritional Supplementation on Muscle Mass, Muscle Strength, Muscle Power and Fatigue in Healthy Elderly Subjects: A Randomized Controlled Double-Blind Study
2019 · multi-ingredient nutritional supplement (SUPP) · Healthy men and women aged 65–80 years, not selected for a diagnosed disease; the group was described as non-sarcopenic and well-nourished
100 mg12 weeks19
Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
2022 · Treatment group · Children aged 6–17 years with obesity (BMI above the 95th percentile for age)
20 mg26 weeks16
Effects of a Long Chain n-3 Polyunsaturated Fatty Acid-rich Multi-ingredient Nutrition Supplement on Body Composition and Physical Function in Older Adults with Low Skeletal Muscle Mass
2022 · supplement (SUPP) · Community-dwelling older adults with low skeletal muscle mass; mean age 74.9 years; 18 men and 19 women in the study overall
150 mg26 weeks—
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease
2017 · resveratrol · Adults with mild-to-moderate dementia due to Alzheimer’s disease; older individuals; sex and age range not specified
500 mg52 weeks56
Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease
2025 · resveratrol · Individuals with mild-to-moderate dementia due to Alzheimer’s disease
500 mg52 weeks56
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial
2013 · resveratrol phase · healthy adult smokers
500 mg30 days50
Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation
2018 · Resv500 arm · Adults aged 40 years or older with type 2 diabetes, BMI below 35 kg/m², treated with diet and/or non-insulin hypoglycemic agents
500 mg26 weeks43
Effect of Resveratrol on Markers of Oxidative Stress and Sirtuin 1 in Elderly Adults with Type 2 Diabetes
2023 · experimental group 500 mg/day (EG500) · Men and women aged 60–74 with type 2 diabetes treated with metformin and/or glibenclamide
500 mg26 weeks43
Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
2019 · resveratrol · Patients with type 2 diabetes and albuminuria
500 mg90 days30
The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease
2019 · resveratrol group · Patients with type 2 diabetes mellitus and coronary heart disease; age and sex not specified
500 mg4 weeks28
Gene Expression of Sirtuin-1 and Endogenous Secretory Receptor for Advanced Glycation End Products in Healthy and Slightly Overweight Subjects after Caloric Restriction and Resveratrol Administration
2018 · RSV group · Adults aged 55–65, healthy and slightly overweight; 12 men and 12 postmenopausal women
500 mg30 days24
Comparison of Resveratrol Supplementation and Energy Restriction Effects on Sympathetic Nervous System Activity and Vascular Reactivity: A Randomized Clinical Trial
2021 · resveratrol (RSV) group · Men and postmenopausal women aged 50–65 years who were healthy and slightly overweight, without the listed cardiometabolic conditions
500 mg30 days24
The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women-A Pilot Randomized Clinical Trial
2024 · Group A (resveratrol and vitamin C placebo) · Women aged 50–60 with early postmenopause and insulin resistance
500 mg90 days13
Serum concentrations and gene expression of sirtuin 1 in healthy and slightly overweight subjects after caloric restriction or resveratrol supplementation: A randomized trial
2017 · resveratrol administration · Healthy adults aged 55–65 years, women and men
500 mg30 days—
Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
2017 · Resv 500 arm · Patients with type 2 diabetes mellitus; age range and sex not specified
500 mg26 weeks—
Resveratrol Enhances Exercise-Induced Cellular and Functional Adaptations of Skeletal Muscle in Older Men and Women
2017 · resveratrol (RSV) · Men and women aged 65–80 years
500 mg12 weeks—
Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial
2025 · resveratrol group · People with relapsing-remitting multiple sclerosis; age and sex not specified
500 mg8 weeks—
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial
2023 · equol/resveratrol combination · Caucasian postmenopausal women aged 50–55 with menopausal complaints and BMI 20 to <25 kg/m²
25 mg1 year38
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial
2012 · resveratrol-enriched grape extract (GE-RES, Stilvid®) · Statin-treated patients in primary prevention of cardiovascular disease
8 mg26 weeks—
A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
2023 · 300 mg/d resveratrol · Adults aged 35–70 with dyslipidemia
300 mg8 weeks43
Effects of resveratrol supplementation on cardiac remodeling in hypertensive patients: a randomized controlled clinical trial
2023 · RES group · Patients with hypertension; age and sex not specified
400 mg26 weeks43
A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
2023 · 600 mg/d resveratrol · Adults aged 35–70 with dyslipidemia
600 mg8 weeks41
Effect of Resveratrol on Markers of Oxidative Stress and Sirtuin 1 in Elderly Adults with Type 2 Diabetes
2023 · experimental group 1000 mg/day (EG1000) · Men and women aged 60–74 with type 2 diabetes treated with metformin and/or glibenclamide
1 g26 weeks40
Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial
2019 · resveratrol group · Patients with PCOS who were candidates for ICSI; age and sex range not stated
800 mg40 days31
Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial
2024 · resveratrol group · Women aged 18–35 with PCOS undergoing ICSI treatment
800 mg60 days28
Effects of resveratrol on inflammatory cytokines in COVID-19 patients: a randomized, double-blinded, placebo-controlled clinical trial
2025 · resveratrol · Patients with COVID-19; age and sex not specified
750 mg10 days24
Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation
2014 · trans-resveratrol · Adults described as healthy and young; age range and sex not specified
250 mg1 day23
The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women-A Pilot Randomized Clinical Trial
2024 · Group B (resveratrol and vitamin C) · Women aged 50–60 with early postmenopause and insulin resistance
500 mg90 days15
Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study
2014 · moderate dose resveratrol condition · Overweight men and women aged 65 years and older
300 mg90 days12
Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study
2014 · high dose resveratrol condition · Overweight men and women aged 65 years and older
1 g90 days10
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
2009 · trans-resveratrol 50 mg group · healthy adult men and women
300 mg—8
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
2009 · trans-resveratrol 100 mg group · healthy adult men and women
600 mg—8
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
2009 · trans-resveratrol 150 mg group · healthy adult men and women
900 mg—8
The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans
2017 · resveratrol group · healthy Japanese adults, males and females, median age 36 years (range 30–50)
1 g4 weeks5
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
2012 · intervention group · Patients with type 2 diabetes mellitus; age and sex not reported
250 mg90 days—
Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
2015 · 1,000 mg resveratrol group · Middle-aged men with metabolic syndrome
1 g120 days—
The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
2017 · intervention group · Patients with type 2 diabetes and chronic periodontitis; age and sex not reported
480 mg4 weeks—
The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
2018 · resveratrol group · Adults with type 2 diabetes; age and sex not reported
800 mg8 weeks—
Resveratrol supplementation decreases blood glucose without changing the circulating CD14(+)CD16(+) monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
2018 · resveratrol group · Patients with type 2 diabetes; age and sex not stated
800 mg8 weeks—
The Effect of Resveratrol Supplementation on Cardio-Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double-Blind Controlled Trial
2019 · trans-resveratrol group · Overweight patients with type 2 diabetes mellitus, BMI 25–30; age and sex not specified
1 g8 weeks—
Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers
2020 · resveratrol treatment group · Patients with polycystic ovary syndrome (PCOS); age and sex details not stated
800 mg40 days—
The effect of resveratrol supplementation on serum levels of asymmetric de-methyl-arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double-blind controlled trial
2020 · resveratrol · Patients with type 2 diabetes; age and sex range not reported
1 g8 weeks—
Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program
2020 · Resveratrol · Adults aged 30–60 years with BMI ≥30 kg/m² and metabolic syndrome features
250 mg90 days—
The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double-blind controlled randomized trial
2021 · trans-resveratrol · Patients with type 2 diabetes mellitus; age range and sex not stated
1 g8 weeks—
Beneficial Role of Resveratrol on Oxidative Stress in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial
2025 · resveratrol · Women with polycystic ovary syndrome (age range not reported)
800 mg60 days—
Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics
2011 · SRT501 group · Adults aged 18 years or older with stage IV colorectal cancer and hepatic metastases, awaiting resection of liver metastases
5 g2 weeks6
Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial
2022 · resveratrol · Patients with type 2 diabetes mellitus taking oral hypoglycemic drugs; age and sex not specified
200 mg24 weeks55
Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation
2018 · Resv40 arm · Adults aged 40 years or older with type 2 diabetes, BMI below 35 kg/m², treated with diet and/or non-insulin hypoglycemic agents
40 mg26 weeks43
A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
2023 · 100 mg/d resveratrol · Adults aged 35–70 with dyslipidemia
100 mg8 weeks41
Role of δ-tocotrienol and resveratrol supplementation in the regulation of micro RNAs in patients with metabolic syndrome: A randomized controlled trial
2023 · TRM group · Adults with metabolic syndrome; age range and sex not specified
300 mg24 weeks41
Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial
2019 · resveratrol · Men and non-pregnant women aged 20–65 with a new diagnosis of dyslipidemia
100 mg60 days35
Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol
2020 · resveratrol group · Adults with heart failure with reduced ejection fraction, NYHA class II or III; mean age 66.7 years; 17 women and 43 men across both trial arms
100 mg90 days30
Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease
2013 · GE-RES, resveratrol-containing grape extract group (group C) · Adults aged 60 on average, men and women with stable coronary artery disease
8.1 mg1 year25
Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer
2012 · P. cuspidatum with 5 mg trans-resveratrol (low-dose resveratrol) · Women at increased breast cancer risk; age range not stated
10 mg12 weeks13
Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer
2012 · P. cuspidatum with 50 mg trans-resveratrol (high-dose resveratrol) · Women at increased breast cancer risk; age range not stated
100 mg12 weeks13
Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes
2018 · resveratrol condition · Overweight males at increased risk of type 2 diabetes, with at least one first-degree relative with type 2 diabetes, BMI 27–35, and disrupted glucose homeostasis
150 mg34 days13
Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion
2014 · trans-resveratrol group · Patients with metabolic syndrome diagnosed according to International Diabetes Federation criteria; age and sex not reported
1.5 g90 days12
The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men
2014 · resveratrol · 11 healthy obese men
150 mg30 days11
Resveratrol supplementation reduces ACE2 expression in human adipose tissue
2021 · Resveratrol · Otherwise healthy males with obesity
150 mg30 days11
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects
2013 · resveratrol · Obese men, mean age 52 ± 2 years
150 mg30 days10
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
2009 · trans-resveratrol 25 mg group · healthy adult men and women
150 mg—8
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
2011 · resveratrol group · patients with type 2 diabetes; age and sex not stated
10 mg4 weeks—
One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease
2012 · resveratrol-rich grape supplement · Patients at high cardiovascular-disease risk undergoing primary prevention, including people with diabetes or hypercholesterolemia plus at least one other cardiovascular risk factor; age and sex not reported
8 mg1 year—
Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects
2012 · RES · Adults with obesity (BMI 30–40); sex and age range not reported
0.66 mmol4 weeks—
Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects
2012 · RTP · Adults with obesity (BMI 30–40); sex and age range not reported
0.66 mmol4 weeks—
Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure
2014 · resveratrol group · Adults with type 2 diabetes mellitus; age and sex not reported
3 g12 weeks—
Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial
2014 · RSV(low) · Middle-aged obese men with metabolic syndrome; mean age 49.3 years
150 mg16 weeks—
Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
2015 · 150 mg resveratrol group · Middle-aged men with metabolic syndrome
150 mg120 days—
Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial
2016 · Resveratrol · Women of reproductive age with polycystic ovary syndrome (PCOS)
1.5 g90 days—
Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
2017 · Resv 40 arm · Patients with type 2 diabetes mellitus; age range and sex not specified
40 mg26 weeks—
Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus
2017 · resveratrol group · patients with type 2 diabetes mellitus; age and sex not specified
28 mg12 weeks—
The Oral Bioavailability of Trans-Resveratrol from a Grapevine-Shoot Extract in Healthy Humans is Significantly Increased by Micellar Solubilization
2018 · Native powder · Healthy adult volunteers; six women and six men
30 mg1 day12
The Oral Bioavailability of Trans-Resveratrol from a Grapevine-Shoot Extract in Healthy Humans is Significantly Increased by Micellar Solubilization
2018 · Liquid micelles · Healthy adult volunteers; six women and six men
30 mg1 day12
Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial
2023 · arm-2 · Women aged 20–35 years with obesity and oligo-anovulatory PCOS
2 g12 weeks55
Resveratrol in Patients with Minimal Hepatic Encephalopathy
2018 · Group A (resveratrol) · Adults aged 25–65 with cirrhosis and minimal hepatic encephalopathy
19.8 mg90 days35
Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation
2014 · trans-resveratrol with piperine · Adults described as healthy and young; age range and sex not specified
250 mg1 day23
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity
2024 · EGCG+RES · Healthy men and women aged 20–50 years with overweight or obesity and normal glucose tolerance
80 mg12 weeks20
An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol
2010 · PCE group · Normal-weight healthy subjects; age and sex not reported
40 mg6 weeks10
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial
2016 · EGCG+RES · Overweight and obese adults; 18 men among 38 participants, mean age 38 ± 2 years; insulin resistance is discussed, but is not specified as an inclusion criterion
80 mg12 weeks—
Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women
2017 · EGCG+RES · Overweight and obese men and women; mean age 37.8 years; 18 men and 19 women enrolled
80 mg12 weeks—
Global testing of shifts in metabolic phenotype
2018 · PP intervention · Overweight and obese adults
80 mg12 weeks—
Modulation of Energy Sensing by Leucine Synergy with Natural Sirtuin Activators: Effects on Health Span
2020 · leucine-resveratrol · Prediabetic subjects; age and sex not stated
50 mg4 weeks—
Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial
2025 · Polyphenol-rich supplement (PPs) · Healthy postmenopausal women aged 45–59 with at least one climacteric symptom
150 mg8 weeks78